Hemoperfusion with Polymyxin B for septic shock after heart surgery
Part of Infections clinical trials.
This trial studies a blood-filter treatment (hemoperfusion with Polymyxin B) to reduce harmful substances in the blood for people who develop septic shock after heart surgery. It may help by lowering inflammation and improving safety, but it also requires meeting specific signs of severe infection and blood/bleeding conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be in the ICU after cardiac (heart) surgery and have signs of worsening severe infection (SOFA score higher by 2 points than your previous check)
- Your tests must show strong inflammation/infection signals (procalcitonin above 2 ng/mL and CRP above 150 ng/mL)
- You must be needing a medication to support blood pressure (norepinephrine infusion)
- You must have evidence of infection in blood (a positive blood culture)
- You must not have active bleeding or a history of heparin-induced thrombocytopenia (a dangerous low-platelet reaction to heparin)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special blood filter (hemoadsorption) for people in septic shock (a severe infection causing very low blood pressure). It aims to see if the filter helps remove harmful substances from the blood and improve recovery.
This trial tests a device that filters extra DNA from the blood of people with septic shock. It may help reduce inflammation and improve recovery.
This study tests whether a blood-filter treatment called hemoperfusion can help critically ill people with sepsis that is not responding to standard shock treatment and is affecting multiple organs. It aims to improve recovery when infections are controlled and inflammation markers are very high.
This trial tests whether a blood filtering treatment called hemoadsorption can help protect blood vessels in people with septic shock. It may be an option for patients who are already on strong blood pressure medications and steroids.
This trial tests whether a blood-filtering device can help people with septic shock by removing harmful substances from the blood. It is for adults who have been diagnosed with septic shock within the last 24 hours.
This study tests a blood-cleaning treatment to remove harmful toxins from the blood of people with severe abdominal infections. It might help their organs recover faster.
Hear when a new Multiple Organ Dysfunction With Severe Endotoxemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.